Today Mydecine Innovations Group Inc. (CSE: MYCO) (OTCMKTS: MYCOF) (FSE:0NF) (“Mydecine” or the “Company”) announced that its subsidiary Mindleap Health Inc. ( “Mindleap” ) signed an agreement with B...